Holen Sie sich die Stockscreener-App
24.27
1.54%
-0.3802
Schlusskurs vom Vortag:
$24.65
Offen:
$24.81
24-Stunden-Volumen:
2,385
Relative Volume:
0.94
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.15%
1M Leistung:
-10.39%
6M Leistung:
-7.37%
1J Leistung:
-6.51%
1-Tages-Spanne:
$24.26
$24.81
1-Wochen-Bereich:
$24.26
$25.28
52-Wochen-Spanne:
$23.51
$31.99
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
Virtus Lifesci Biotech Clinical Trials Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
24.27 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
291.68 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
589.49 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
592.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
242.00 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
515.27 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
7 Best-Performing Biotech ETFs for January 2025 - NerdWallet
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Technical Data - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
(BBC) Trading Signals - Stock Traders Daily
Long Term Trading Analysis for (BBC) - Stock Traders Daily
Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target? - Yahoo Finance
Where are the Opportunities in (VABS) - Stock Traders Daily
FYC: Smart Or Speculative Small-Cap Growth ETF? (NASDAQ:FYC) - Seeking Alpha
(BBC) Trading Advice - Stock Traders Daily
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Trading Up 2% - Defense World
Where are the Opportunities in (BBC) - Stock Traders Daily
The Great Rotation: Just Getting Started? - ETF Trends
(BBC) Technical Pivots with Risk Controls - Stock Traders Daily
Time for Healthcare ETFs? - Yahoo Finance
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Shares Up 3.1% - Defense World
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - Seeking Alpha
5 Top ETFs of Last Week - Yahoo Finance
Inflation Cools in June, Triggers Spike in Laggard ETFs - Markets Insider
UK house prices likely to rise modestly this year and into 2025, says Halifax - Yahoo News UK
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
Pharma Stocks Look Cheap. Here's One Way To Invest. - Barchart
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - Opto RoW
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
How to Pick a Biotech ETF - Investment U
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Yahoo Finance
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com UK
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
More than Just COVID: Hot ETFs for Medical Breakthroughs - ETF Trends
For 2021 Upside, Bet on the SBIO Biotech ETF - ETF Trends
Top Tech ETFs Right Now - Benzinga
ETF of the Week: iShares MSCI China ETF (MCHI) - ETF Trends
ETF of the Week: Vanguard Total Stock Market ETF (VTI) - ETF Trends
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):